A detailed history of Envestnet Asset Management Inc transactions in Amgen Inc stock. As of the latest transaction made, Envestnet Asset Management Inc holds 1,275,770 shares of AMGN stock, worth $364 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
1,275,770
Previous 1,408,785 9.44%
Holding current value
$364 Million
Previous $440 Million 6.61%
% of portfolio
0.14%
Previous 0.16%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$309.38 - $337.38 $41.2 Million - $44.9 Million
-133,015 Reduced 9.44%
1,275,770 $411 Million
Q2 2024

Aug 08, 2024

BUY
$262.75 - $319.31 $28.1 Million - $34.2 Million
107,134 Added 8.23%
1,408,785 $440 Million
Q1 2024

May 13, 2024

BUY
$268.87 - $324.56 $24 Million - $29 Million
89,351 Added 7.37%
1,301,651 $370 Million
Q4 2023

Feb 13, 2024

SELL
$255.7 - $288.46 $11.8 Million - $13.3 Million
-46,273 Reduced 3.68%
1,212,300 $349 Million
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $44.4 Million - $55.1 Million
203,072 Added 19.24%
1,258,573 $338 Million
Q2 2023

Aug 04, 2023

SELL
$214.27 - $253.37 $350 Million - $414 Million
-1,635,217 Reduced 60.77%
1,055,501 $234 Million
Q1 2023

May 11, 2023

BUY
$225.79 - $275.2 $415 Million - $506 Million
1,839,455 Added 216.09%
2,690,718 $650 Million
Q4 2022

Feb 07, 2023

SELL
$229.03 - $291.01 $16.9 Million - $21.4 Million
-73,579 Reduced 7.96%
851,263 $224 Million
Q3 2022

Nov 10, 2022

BUY
$224.46 - $253.15 $11.7 Million - $13.2 Million
51,964 Added 5.95%
924,842 $208 Million
Q2 2022

Aug 03, 2022

BUY
$230.71 - $256.74 $10.5 Million - $11.7 Million
45,688 Added 5.52%
872,878 $212 Million
Q1 2022

May 04, 2022

BUY
$219.27 - $242.57 $54 Million - $59.8 Million
246,435 Added 42.43%
827,190 $200 Million
Q4 2021

Feb 04, 2022

BUY
$198.88 - $227.6 $3.66 Million - $4.19 Million
18,422 Added 3.28%
580,755 $131 Million
Q3 2021

Oct 07, 2021

SELL
$212.27 - $248.7 $11.5 Million - $13.5 Million
-54,249 Reduced 8.8%
562,333 $120 Million
Q2 2021

Aug 04, 2021

SELL
$233.58 - $259.14 $6,073 - $6,737
-26 Reduced -0.0%
616,582 $150 Million
Q1 2021

May 04, 2021

BUY
$221.91 - $258.6 $16 Million - $18.6 Million
71,937 Added 13.21%
616,608 $153 Million
Q4 2020

Feb 02, 2021

BUY
$216.38 - $257.67 $2.15 Million - $2.56 Million
9,949 Added 1.86%
544,671 $125 Million
Q3 2020

Oct 09, 2020

BUY
$234.65 - $260.95 $2.12 Million - $2.35 Million
9,021 Added 1.72%
534,722 $136 Million
Q2 2020

Jul 08, 2020

SELL
$197.81 - $242.74 $15.3 Million - $18.8 Million
-77,424 Reduced 12.84%
525,701 $124 Million
Q1 2020

Apr 23, 2020

BUY
$182.24 - $241.7 $10.1 Million - $13.4 Million
55,308 Added 10.1%
603,125 $122 Million
Q4 2019

Feb 11, 2020

BUY
$189.21 - $243.2 $12 Million - $15.4 Million
63,361 Added 13.08%
547,817 $132 Million
Q3 2019

Oct 17, 2019

BUY
$174.11 - $208.62 $1.07 Million - $1.29 Million
6,169 Added 1.29%
484,456 $93.7 Million
Q2 2019

Aug 02, 2019

SELL
$166.7 - $195.41 $9.78 Million - $11.5 Million
-58,649 Reduced 10.92%
478,287 $88.1 Million
Q1 2019

May 10, 2019

BUY
$180.87 - $203.88 $5.77 Million - $6.51 Million
31,928 Added 6.32%
536,936 $102 Million
Q4 2018

Feb 13, 2019

BUY
$178.4 - $208.25 $73.2 Million - $85.4 Million
410,208 Added 432.71%
505,008 $98.3 Million
Q3 2018

Nov 14, 2018

SELL
$185.29 - $208.89 $8.16 Million - $9.2 Million
-44,021 Reduced 31.71%
94,800 $19.7 Million
Q2 2018

Aug 10, 2018

BUY
$166.05 - $186.51 $13.8 Million - $15.5 Million
83,185 Added 149.52%
138,821 $25.6 Million
Q1 2018

May 09, 2018

SELL
$169.43 - $198.0 $7.06 Million - $8.25 Million
-41,682 Reduced 42.83%
55,636 $9.44 Million
Q4 2017

Feb 20, 2018

SELL
$168.79 - $188.59 $309,223 - $345,496
-1,832 Reduced 1.85%
97,318 $16.9 Million
Q3 2017

Nov 13, 2017

SELL
$167.29 - $191.0 $652,431 - $744,900
-3,900 Reduced 3.78%
99,150 $18.5 Million
Q2 2017

Aug 14, 2017

BUY
N/A
103,050
103,050 $17.7 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $153B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.